Hematology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Challenges in the Management of Hemophilia (Deadline: 20 May 2024)
- New Advances in Thrombosis and Hemostasis (Deadline: 25 May 2024)
- New Advances in Cutaneous Lymphomas (Deadline: 29 May 2024)
- Deep Vein Thrombosis and Pulmonary Embolism: Clinical Treatment and Management (Deadline: 31 May 2024)
- Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management—Volume II (Deadline: 25 June 2024)
- Congenital Bleeding Disorders: Diagnosis, Treatment and Future Opportunities (Deadline: 30 June 2024)
- Prognostic and Diagnostic Testing in Onco-Haematological Diseases in the Era of Novel Therapies: Current Updates and Future Perspectives (Deadline: 30 June 2024)
- Antibody-Mediated Thrombotic Diseases (Deadline: 10 July 2024)
- Diagnosis and Management of Blood Diseases (Deadline: 30 July 2024)
- Advances in Pediatric Leukemia (Deadline: 31 July 2024)
- Review Special Issue Series: Recent Advances in Hematology (Deadline: 31 July 2024)
- Advancements and Challenges in Treating Chronic Myeloproliferative Neoplasms (Deadline: 25 August 2024)
- Haemophilia: Current Treatment and Clinical Outcomes, Challenges and Opportunities (Deadline: 31 August 2024)
- Targeted Treatment of Hematological Malignancy (Deadline: 31 August 2024)
- Clinical Aspects in the Treatment of Elderly Patients with Acute Myeloid Leukemia (Deadline: 20 September 2024)
- Acute Myeloid Leukemia: Latest Advances in the Diagnostics, Therapeutic Strategies and Clinical Management (Deadline: 20 September 2024)
- Thromboembolic Disease and Antithrombotic Therapy (Deadline: 20 September 2024)
- Innovative Treatments for Anemias (Deadline: 24 September 2024)
- Thromboembolic Disease and Its Complications (Deadline: 25 September 2024)
- Management, Diagnosis and Pathophysiology of Antiphospholipid Syndrome: Current Practice and Future Perspectives—Volume II (Deadline: 31 October 2024)
- Myeloproliferative Neoplasms (MPN): Recent Advances, Current Practices and Future Perspectives (Deadline: 31 October 2024)
- Clinical Updates on Haemophilia (Deadline: 20 December 2024)
- Emerging Therapies for Multiple Myeloma (Deadline: 31 December 2024)
- Thrombosis: Latest Advances and Prospects (Deadline: 25 February 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: